Grant: CIHR Fellowship
McMaster University
$90,000.00
Enhancing methods for analyzing and interpreting patient-reported outcome measures in clinical research and evidence-based decision-making
EF 2017-18
Résumé
In deciding whether to use a particular treatment for conditions such as depression, arthritis, or heart disease, doctors and patients must balance the benefits against the side effects and burden. To make this trade-off, they must understand the likely degree of benefit in symptoms and wellbeing. These outcomes are typically measured from directly asking patients using questionnaires in which patients describe how they are feeling. We call such questionnaires patient-reported outcomes (PROs).
PRO measures (PROMs) are increasingly used in clinical trials and systematic reviews to evaluate health care interventions. Information obtained from PROMs can guide clinical decisions and inform shared-decision making. However, the use of PROMs involves challenges, the most important of which is deciding if a particular treatment effect is trivial, small but important, moderate or large. For instance, without further information, clinicians may find it difficult to grasp the importance of a three-point difference on a questionnaire that aims to assess health-related quality of life in patients with chronic obstructive pulmonary disease.
One way to make this judgment is to consider the minimal important difference (MID), the smallest change in a PROM score that is important enough that patients would consider a change in treatment to achieve that benefit.
Over the past 3 decades, researchers have developed statistical methods to estimate MIDs for various PROMs. However, the studies using these methods are not planned or conducted equally well. Though the MID is an alluring concept, there is much we are still learning about MID methodology.
We plan to lead two projects that will further advance MID methods and optimize the presentation and interpretation of results from PROM in clinical trials, systematic reviews and clinical practice guidelines to inform evidence-based decision-making in clinical practice, ultimately enhancing quality of care and patient outcomes.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
376479
Name
Devji Tahira S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Enhancing methods for analyzing and interpreting patient-reported outcome measures in clinical research and evidence-based decision-making
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Clinical Practice Guidelines; Clinical Trials; Continuous Outcomes; Minimal Important Difference; Patient-Reported Outcomes; Quality Of Life; Systematic Reviews
Abstract
In deciding whether to use a particular treatment for conditions such as depression, arthritis, or heart disease, doctors and patients must balance the benefits against the side effects and burden. To make this trade-off, they must understand the likely degree of benefit in symptoms and wellbeing. These outcomes are typically measured from directly asking patients using questionnaires in which patients describe how they are feeling. We call such questionnaires patient-reported outcomes (PROs).
PRO measures (PROMs) are increasingly used in clinical trials and systematic reviews to evaluate health care interventions. Information obtained from PROMs can guide clinical decisions and inform shared-decision making. However, the use of PROMs involves challenges, the most important of which is deciding if a particular treatment effect is trivial, small but important, moderate or large. For instance, without further information, clinicians may find it difficult to grasp the importance of a three-point difference on a questionnaire that aims to assess health-related quality of life in patients with chronic obstructive pulmonary disease.
One way to make this judgment is to consider the minimal important difference (MID), the smallest change in a PROM score that is important enough that patients would consider a change in treatment to achieve that benefit.
Over the past 3 decades, researchers have developed statistical methods to estimate MIDs for various PROMs. However, the studies using these methods are not planned or conducted equally well. Though the MID is an alluring concept, there is much we are still learning about MID methodology.
We plan to lead two projects that will further advance MID methods and optimize the presentation and interpretation of results from PROM in clinical trials, systematic reviews and clinical practice guidelines to inform evidence-based decision-making in clinical practice, ultimately enhancing quality of care and patient outcomes.
Competitiondate
201711
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Devji, Tahira S
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~